SM
BIO icon

Simcah Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Simcah Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$4.96M Buy
+40,097
New +$4.89M 5.72% 6

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simcah Management's BIO Position: Q4 2013 in Review

Simcah Management opened a new position in Bio-Rad Laboratories Class A (BIO) in Q4 2013: 40,097 shares worth $4.96M. The stake represents 5.72% of the portfolio and ranks #6 among its holdings.

198 funds tracked by Wall St. Rank hold BIO as of Q4 2013.

  • Simcah Management held 40,097 shares of Bio-Rad Laboratories Class A worth $4.96M as of Q4 2013.
  • Bio-Rad Laboratories Class A was a new Simcah Management position in Q4 2013.
  • Bio-Rad Laboratories Class A made up 5.72% of Simcah Management's portfolio in Q4 2013, its #6 holding.
  • 198 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2013.

Based on Simcah Management's 13F filing for Q4 2013, filed 14 Feb 2014.